Skip to main content
Premium Trial:

Request an Annual Quote

Idaho Technology Seeking FDA Clearance for Additional Pathogens on FilmArray System

NEW YORK (GenomeWeb News) – Idaho Technology said late on Monday that it is seeking US regulatory approval for five additional pathogens for its FilmArray Respiratory Panel.

The company is seeking 510(k) clearance from the US Food and Drug Administration for Bordetella pertiussis; Chlamydophila pneumoniae; Mycoplasma pneumoniae; Coronavirus 229E; and Coronavirus OC43. According to Idaho Technology, no assays are currently cleared by FDA for the five pathogens.

FilmArray, a multiplex PCR assay, was cleared by the agency for 15 other respiratory pathogens last year.

Idaho Technology said that it is developing other applications for the FilmArray system, including a blood culture ID panel, gastrointestinal pathogens panel, and an STD panel, and expects to start clinically testing the blood culture ID panel later this year.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.